NASDAQ:IMMX | Income Statement | Immix Biopharma, Inc.

Complete source-backed income-statement history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$5.33M$12.46M-$12.46M$913,663.00-$11.54M$14,322.00-$11.56M-$0.18-$0.1863,771,37763,771,377
2026-03-31$5.98M$10.8M-$10.8M$717,168.00-$10.09M-$10.09M-$0.18-$0.1855,369,12355,369,123
2025-12-31$5.73M$10.89M-$10.89M$216,712.00-$10.68M$11,266.00-$10.69M-$0.28-$0.282,419,5292,419,529
2025-09-30$4.58M$7.66M-$7.66M$84,539.00-$7.58M$7,722.00-$7.59M-$0.24-$0.2431,926,65131,926,651
2025-06-30$3.97M$6.72M-$6.72M$104,056.00-$6.61M$8,914.00-$6.62M-$0.22-$0.2229,983,76429,983,764
2025-03-31$1.98M$4.68M-$4.68M$150,219.00-$4.53M$9,822.00-$4.54M-$0.15-$0.1529,701,08029,701,080
2024-12-31$1.37M$4.99M-$4.99M$185,851.00-$4.8M$10,785.00-$4.81M-$0.16-$0.16426,081426,081
2024-09-30$4.45M$7.39M-$7.39M$256,680.00-$7.14M$11,144.00-$7.15M-$0.24-$0.2429,424,44429,424,444
2024-06-30$2.22M$4.7M-$4.7M$306,915.00-$4.4M$10,269.00-$4.39M-$0.15-$0.1528,785,22328,785,223
2024-03-31$3.25M$5.59M-$5.59M$267,908.00-$5.32M$8,839.00-$5.26M-$0.22-$0.2223,438,14323,438,143
2023-12-31$3.1M$5.38M-$5.38M$228,575.00-$5.15M$8,089.00-$5.09M-$0.24-$0.241,480,0461,480,046
2023-09-30$2.11M$4.52M-$4.52M$186,691.00-$4.34M$6,807.00-$4.28M-$0.23-$0.2318,578,41418,578,414
2023-06-30$2.21M$3.72M-$3.72M$128,848.00-$3.59M$6,349.00-$3.58M-$0.24-$0.2415,038,98915,038,989
2023-03-31$1.32M$2.52M-$2.52M$27,892.00-$2.49M$5,170.00-$2.48M-$0.18-$0.1813,897,18413,897,184
2022-12-31$2.26M$3.79M-$3.79M$0.00-$3.79M$5,259.00-$3.8M-$0.27-$0.278,0488,048
2022-09-30$695,937.00$1.53M-$1.53M-$1.53M$1,672.00-$1.54M-$0.11-$0.1113,924,83213,924,832
2022-06-30$607,751.00$1.56M-$1.56M-$109.00-$1.56M$1,715.00-$1.56M-$0.11-$0.1113,881,41413,881,414
2022-03-31$629,531.00$1.33M-$1.33M-$388.00-$1.33M$1,622.00-$1.33M-$0.1013,830,374
2021-12-31$9,236.00$598,338.00-$598,338.00-$22.16M-$22.75M$1,477.00-$22.76M-$6.16297,611
2021-09-30$29,690.00$347,991.00-$347,991.00-$53,937.00-$401,928.00$1,337.00-$403,265.00-$0.123,375,000
2021-06-30$62,761.00$243,165.00-$243,165.00-$36,135.00-$207,030.00$1,608.00-$208,638.00-$0.063,375,000
2021-03-31$24,840.00$162,520.00-$162,520.00-$852,544.00-$1.02M$1,591.00-$1.02M-$0.303,375,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$16.26M$29.96M-$29.96M$555,526.00-$29.4M$37,724.00-$29.44M-$0.89-$0.8932,965,70632,965,706
2024-12-31$11.29M$22.67M-$22.67M$1.02M-$21.66M$41,037.00-$21.61M-$0.76-$0.7628,285,63728,285,637
2023-12-31$8.74M$16.14M-$16.14M$572,006.00-$15.57M$26,415.00-$15.43M-$0.89-$0.8917,341,14617,341,146
2022-12-31$4.2M$8.22M-$8.22M-$497.00-$8.22M$10,268.00-$8.23M-$0.59-$0.5913,887,30913,887,309
2021-12-31$126,527.00$1.35M-$1.35M-$23.03M-$24.38M$6,013.00-$24.38M-$6.643,672,6113,672,611
2020-12-31$248,149.00$453,852.00-$453,852.00-$676,464.00-$1.13M$17,547.00-$1.15M3,375,000